Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > Azaya Therapeutics, Inc. Elects Ze’ev Shaked, Ph.D., to Board of Directors

Abstract:
Brings Track Record of Successful Product Commercialization

Azaya Therapeutics, Inc. Elects Ze’ev Shaked, Ph.D., to Board of Directors

SAN ANTONIO, TX | Posted on May 31st, 2007

Azaya Therapeutics, Inc. today announced the election of Dr. Ze'ev Shaked to its Board of Directors. Dr. Shaked has extensive managerial and pharmaceutical product development experience in commercializing new drug products. He most recently was President and CEO of Spherics, Inc., where he transformed the company into a product-driven company with an attractive product pipeline, and where he raised more than $25 million from the venture capital industry.

Prior to Spherics, Dr. Shaked was Chief Operating Officer of ILEX Oncology, Inc., in San Antonio, Texas. He was instrumental in ILEX obtaining ownership and FDA approval for CAMPATH and Clolar, two of its commercialized products. In addition, Dr. Shaked has held a number of senior research and development and corporate management positions at ImmuLogic Pharmaceutical Corporation, Berlex Biosciences, Inc., Triton Biosciences, Inc., CODON Corporation, and Chiron Corporation. He obtained his Ph.D. in Organic Chemistry and Applied Biochemistry from the Massachusetts Institute of Technology.

"Ze'ev Shaked has an outstanding track record in the biopharmaceutical industry and in overseeing the development of new drugs," said John Kerr, chairman of the board of Azaya. "His wealth of scientific experience will be invaluable in guiding the overall development of Azaya's pipeline of products."

####

About Azaya Therapeutics, Inc.
Azaya Therapeutics, Inc., is an emerging nanotherapy company with an innovative technology platform – Protein Stabilized Nanoparticles – (PSNTM) designed to significantly improve the efficacy and safety of water insoluble pharmaceutical agents. Azaya is initially building an in-house pipeline of safer and more efficacious nanoparticle chemotherapy drug products. Azaya was granted a patent on this technology in February 2007.

For more information, please click here

Contacts:
Azaya Therapeutics, San Antonio
Michael T. Dwyer, 210-341-6600
or
Dublin & Associates
Eric Whittington, 210-227-0221, ext. 239

Copyright © Business Wire 2007

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Nanomedicine

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

UTSA study describes new minimally invasive device to treat cancer and other illnesses: Medicine diffusion capsule could locally treat multiple ailments and diseases over several weeks December 3rd, 2016

Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016

Announcements

Fast, efficient sperm tails inspire nanobiotechnology December 5th, 2016

Journal Nanotechnology Progress International (JONPI) Volume 6, issue 2 coming out soon! December 5th, 2016

Infrared instrumentation leader secures exclusive use of Vantablack coating December 5th, 2016

Construction of practical quantum computers radically simplified: Scientists invent ground-breaking new method that puts quantum computers within reach December 5th, 2016

Appointments/Promotions/New hires/Resignations/Deaths

Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016

Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016

Park Systems Global Expansion in AFM Market Includes Appointment of New Executives April 23rd, 2016

GLOBALFOUNDRIES Adds Alain Mutricy as Head of Product Management Group March 3rd, 2016

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project